HIPEC after neoadjuvant chemotherapy is associated with acceptable toxicity and favorable quality of life in newly diagnosed advanced ovarian cancer patients (509)
Year: 2022
Type: article
Study design: Clinical Trial
Source: Gynecologic Oncology
Authors: Anya Menzies, Erik Usher, Fang-Chi Hsu, Edward Levine, Samuel Lentz, Michael Kelly
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4295235445
